Literature DB >> 17592268

The spectrum of malignancy in craniopharyngioma.

Fausto J Rodriguez1, Bernd W Scheithauer, Shigeru Tsunoda, Kalman Kovacs, Sergio Vidal, David G Piepgras.   

Abstract

Craniopharyngiomas are low-grade epithelial neoplasms occurring almost exclusively in the sellar/suprasellar region. Histologic malignancy is extremely rare; the literature consists mostly of isolated case reports. Herein, we report 3 patients with craniopharyngiomas exhibiting histologic malignancy, 2 of which received radiation therapy before its appearance. Hematoxylin and eosin-stained slides and selected immunohistochemical stains were reviewed in all cases. Microvessel density analysis was performed in case 2. The patients included 2 men and 1 woman, age 14, 31, and 58 years at presentation, respectively. All patients expired 3 months to 9 years after first resection and 3 to 9 months after identification of histologic malignancy. The latter developed after multiple recurrences and radiation therapy in 2 cases, but seemed to arise de novo in 1 case resembling odontogenic ghost cell carcinoma and lacking any definite low-grade craniopharyngioma precursor. The malignant component of the other 2 cases resembled squamous cell carcinoma and low-grade myoepithelial carcinoma, respectively. The MIB-1 labeling index was markedly increased in the malignant component in comparison with the low-grade precursor. Malignant transformation in craniopharyngiomas, although rare, does exist. It assumes varied histologic appearances, usually after multiple recurrences and radiation therapy, and has a near uniformly fatal outcome. De novo malignancy in odontogenic tumors of the sella is even more unusual, but also has an ominous prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592268     DOI: 10.1097/PAS.0b013e31802d8a96

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

Review 1.  Malignant transformation of craniopharyngioma: case report and review of the literature.

Authors:  Shuzi Gao; Xiangen Shi; Yanxia Wang; Hai Qian; Chengyin Liu
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

2.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

3.  Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.

Authors:  Gianluca Marucci; Dario de Biase; Matteo Zoli; Marco Faustini-Fustini; Antonella Bacci; Ernesto Pasquini; Michela Visani; Diego Mazzatenta; Giorgio Frank; Giovanni Tallini
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 4.  [New aspects of tumor pathology of the pituitary].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 5.  De novo malignant craniopharyngioma: case report and literature review.

Authors:  Libero Lauriola; Francesco Doglietto; Mariangela Novello; Francesco Signorelli; Nicola Montano; Roberto Pallini; Giulio Maira
Journal:  J Neurooncol       Date:  2010-09-03       Impact factor: 4.130

Review 6.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

Review 7.  Craniopharyngioma: historical notes.

Authors:  J Lindholm; E H Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 8.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

9.  Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor.

Authors:  Suk Keun Lee; Yeon Sook Kim
Journal:  Korean J Pathol       Date:  2013-06-25

10.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.